JNJ

Johnson & Johnson
NYSEHEALTHCAREDRUG MANUFACTURERS - GENERAL

Key Statistics

Market Cap
$566.98B
P/E Ratio
21.33
EPS
$11.03
Beta
0.33
52W High
$251.71
52W Low
$137.67
50-Day MA
$234.14
200-Day MA
$194.58
Dividend Yield
2.18%
Profit Margin
28.50%
Forward P/E
20.41
PEG Ratio
1.65

About Johnson & Johnson

Johnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government.

Official WebsiteUSAFY End: December

Fundamentals

Revenue (TTM)$94.19B
Gross Profit (TTM)$64.13B
EBITDA$33.84B
Operating Margin24.00%
Return on Equity35.00%
Return on Assets8.68%
Revenue/Share (TTM)$39.13
Book Value$33.87
Price-to-Book6.95
Price-to-Sales (TTM)6.02
EV/Revenue6.31
EV/EBITDA14.49
Quarterly Earnings Growth (YoY)48.60%
Quarterly Revenue Growth (YoY)9.10%
Shares Outstanding$2.41B
Float$2.41B
% Insiders0.06%
% Institutions75.75%

Historical Volatility

HV 10-Day
11.84%
HV 20-Day
15.21%
HV 30-Day
15.82%
HV 60-Day
15.83%
HV Rank
46.8%

Volatility is currently contracting

Analyst Ratings

Consensus ($241.08 target)
5
Strong Buy
9
Buy
10
Hold
1
Strong Sell
Data last updated: 3/25/2026